Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Podcast TCTMD Talking Points

The FAVOR III Europe Trial

December 03, 2025

Presentation TCT 2025

TCT 238: Initial Experience with New Version of Magnesium Bioabsorbable Scaffold FREESOLVETM: Clinical and Angiographic-based Murray’s QFR and Radial Walls Strain Evaluation

Presenter: Stefano Galli

October 28, 2025

Presentation TCT 2025

TCT 79: Assessing Long-Term Prognosis After PCI: A Comparative Sensitivity Analysis of Post-PCI FFR and QFR

Presenter: Bettina Csanádi

October 27, 2025

Presentation TCT 2025

TCT 654: Functional Classification based on the Quantitative Flow Ratio and Long-term Clinical Outcomes in Three-Vessel Disease: the CREDO-Kyoto Registry Cohort-3 QFR Study

Presenter: Akinori Tamura

October 26, 2025

Presentation TCT 2025

TCT 648: The Prognostic Effect of QFR-based Functionally Complete versus Incomplete Revascularization: A Systematic Review and Meta-Analysis

Presenter: Kyriakos Dimitriadis

October 26, 2025

Presentation TCT 2025

TCT 645: Physiologic Improvement After PCI: Prognostic Role of Delta FFR and Delta QFR

Presenter: Bettina Csanádi

October 26, 2025

Presentation TCT 2025

TCT 213: Core-Laboratory Murray Law-based QFR (µFR) versus FFR : A FAVOR III Europe Subdstudy

Presenter: Sophie Kjerstein Kristensen

October 26, 2025

Presentation TCT 2025

TCT 412: Comprehensive Multimodal Assessment of Vulnerable Coronary Plaque Integrating Angiographic-Based Murray’s QFR, Radial Wall Strain (RWS), IVUS-NIRS and CCTA

Presenter: Stefano Galli

October 26, 2025

Presentation TCT 2025

QFR vs. FFR for Coronary Revascularization Guidance: 2-Year Follow-up of the FAVOR III Europe Trial

Presenter: Birgitte Krogsgaard Andersen

October 25, 2025

News Conference News EuroPCR 2025

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

L.A. McKeown

May 22, 2025

News Daily News

Deferred Revascularization Safer When Guided by FFR vs QFR: FAVOR III Europe

Caitlin E. Cox

January 09, 2025

Advertisement

The FAVOR III Europe Trial

TCT 238: Initial Experience with New Version of Magnesium Bioabsorbable Scaffold FREESOLVETM: Clinical and Angiographic-based Murray’s QFR and Radial Walls Strain Evaluation

TCT 79: Assessing Long-Term Prognosis After PCI: A Comparative Sensitivity Analysis of Post-PCI FFR and QFR

TCT 654: Functional Classification based on the Quantitative Flow Ratio and Long-term Clinical Outcomes in Three-Vessel Disease: the CREDO-Kyoto Registry Cohort-3 QFR Study

TCT 648: The Prognostic Effect of QFR-based Functionally Complete versus Incomplete Revascularization: A Systematic Review and Meta-Analysis

TCT 645: Physiologic Improvement After PCI: Prognostic Role of Delta FFR and Delta QFR

TCT 213: Core-Laboratory Murray Law-based QFR (µFR) versus FFR : A FAVOR III Europe Subdstudy

TCT 412: Comprehensive Multimodal Assessment of Vulnerable Coronary Plaque Integrating Angiographic-Based Murray’s QFR, Radial Wall Strain (RWS), IVUS-NIRS and CCTA

QFR vs. FFR for Coronary Revascularization Guidance: 2-Year Follow-up of the FAVOR III Europe Trial

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

Deferred Revascularization Safer When Guided by FFR vs QFR: FAVOR III Europe

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content